Public signalCompany raiseAuto-indexed · Unverified
NGM Bio Holdings, Inc. raised $73.2M
NGM Bio Holdings, Inc.· SOUTH SAN FRANCISCO, US· Biotechnology· Filed Jul 17, 2024
NGM Bio Holdings, Inc. reported raising capital. Based in SOUTH SAN FRANCISCO, CALIFORNIA, US. First sale reported 2024-07-05. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$73.2M
Confidence90%
Raised
$73.2M
Investors
25
Incorporated
2024
Jurisdiction
DELAWARE
On the record
- Location
- SOUTH SAN FRANCISCO, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $73.2M
- Target amount
- $122.0M
- Filing date
- Jul 17, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2024
- Industry group
- Biotechnology
- Number of investors
- 25
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $122.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Carole Ho
Director
South San Francisco, US
Daniel Kaplan
Executive Officer
South San Francisco, US
David Goeddel
Director
South San Francisco, US
David J. Woodhouse
Director
South San Francisco, US
Hsiao D. Lieu
Executive Officer
South San Francisco, US
Jean-Frederic Viret
Executive Officer
South San Francisco, US
Kara Calhoun
Executive Officer
South San Francisco, US
Peter Svennilson
Director
SAN FRANCISCO, US
Roger M. Perlmutter
Director
Hayward, US
Shelly D. Guyer
Director
South San Francisco, US
Valerie Pierce
Executive Officer
South San Francisco, US
William J. Rieflin
Director
South San Francisco, US
Sources & provenance
“Operating company sold 73,223,979 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 17, 2024. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with NGM Bio Holdings, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record